MOSCOW, March 14 – RIA Novosti. First Deputy Head of the European Commission Frans Timmermans admitted that the European Union has not avoided mistakes in its strategy for vaccination against COVID-19. He stated this in an interview with Tagesspiegel AM Sonntag.
“It is true that mistakes were made in ordering vaccines both in Brussels and in the Member States,” he said, adding that he understands the requirement to deliver the drugs as quickly as possible.
At the same time, Timmermans called for summing up after the pandemic: then it will be possible to see what was wrong and what was right. He called the joint order of vaccines the right decision, although he noted that this agreement is in the interests of richer countries such as Germany.
There are currently four vaccines registered in the European Union: from Pfizer / BioNTech, Moderna, AstraZeneca and Johnson & Johnson. In addition, the European Commission has signed contracts for the supply of the French-British drug Sanofi-GSK and the German CureVac, but their manufacturers have not yet applied for registration.
It was planned that the European Union will receive at least 2.3 billion doses of vaccines and by mid-September will be able to vaccinate 70 percent of the population. But in recent weeks, there have been problems with the supply of the drug from Pfizer / BioNTech and AstraZeneca, so vaccination plans may be thwarted.
Last week, the European Medicines Agency launched an examination of the Russian Sputnik V vaccine. It will be checked for compliance with European standards for efficiency, safety and quality. Consideration will take place under an accelerated procedure, but the approval timeline was not named.
The Russian direct investment fund has signed an agreement with the Swiss company Adienne Pharma & Biotech to manufacture Sputnik V in Spain, and in July the vaccine will begin to be produced in Italy.